When the pros and cons of prostate cancer (PCa) treatment are spelled out using an online interactive program, more patients with low-risk PCa choose active surveillance.
Continue Reading
John Schieszer reports in today’s Medical Minute that the vast majority of men diagnosed with low-risk PCa undergo aggressive treatment rather than active surveillance.
However, this new online program may help better guide patients to their best treatment option for long-term survival.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.